Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Gains from Sales and Divestitures: 2012-2020

Historic Gains from Sales and Divestitures for National Research (NRC) over the last 6 years, with Q4 2020 value amounting to $71378.0.

  • National Research's Gains from Sales and Divestitures changed N/A to $71378.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $71378.0, marking a year-over-year change of. This contributed to the annual value of $71378.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, National Research's Gains from Sales and Divestitures is $71378.0.
  • National Research's 5-year Gains from Sales and Divestitures high stood at $73506.0 for Q4 2017, and its period low was $13611.0 during Q2 2018.
  • For the 4-year period, National Research's Gains from Sales and Divestitures averaged around $31095.9, with its median value being $20892.0 (2016).
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first soared by 25183.8% in 2017, then tumbled by 8148.31% in 2018.
  • Over the past 4 years, National Research's Gains from Sales and Divestitures (Quarter) stood at $20892.0 in 2016, then surged by 251.84% to $73506.0 in 2017, then plummeted by 81.48% to $13611.0 in 2018, then skyrocketed by 424.41% to $71378.0 in 2020.
  • Its Gains from Sales and Divestitures stands at $71378.0 for Q4 2020, versus $34622.0 for Q3 2020 and $34622.0 for Q2 2020.